Beth A Hellerstedt Selected Research

Beth A Hellerstedt Research Topics

3	Prostatic Neoplasms (Prostate Cancer) 07/2003 - 05/2002
2	Neoplasms (Cancer) 01/2019 - 06/2013
2	Breast Neoplasms (Breast Cancer) 01/2018 - 10/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Pathologic Complete Response 01/2018
1	Cardiotoxicity 01/2018
1	Amenorrhea 10/2016
1	Urinary Bladder Neoplasms (Bladder Cancer) 06/2013
1	Carcinoma (Carcinomatosis) 06/2013
1	Wounds and Injuries (Trauma) 04/2010
1	Lymphocytosis 04/2010
1	Viremia 04/2010

3	AndrogensIBA 07/2003 - 05/2002
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 10/2016
1	cabozantinibIBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	Capecitabine (Xeloda)FDA Link 01/2018
1	Trastuzumab (Herceptin)FDA Link 01/2018
1	Fluorouracil (Carac)FDA LinkGeneric 01/2018
1	Docetaxel (Taxotere)FDA Link 01/2018
1	Epirubicin (Ellence)FDA LinkGeneric 01/2018
1	Estrogen ReceptorsIBA 10/2016
1	Estradiol (Delestrogen)FDA LinkGeneric 10/2016
1	Tamoxifen FDA LinkGeneric 10/2016
1	Letrozole (Femara)FDA LinkGeneric 10/2016
1	Aromatase InhibitorsIBA 10/2016
1	Cisplatin (Platino)FDA LinkGeneric 06/2013
1	Sunitinib (Sutent)FDA Link 06/2013
1	Gemcitabine FDA Link 06/2013
1	Immunoglobulin M (IgM)IBA 04/2010
1	Metalloproteases (Metalloproteinases)IBA 06/2002
1	Angiogenesis InhibitorsIBA 06/2002
1	Diphosphonates (Bisphosphonates)IBA 06/2002

5	Therapeutics 10/2016 - 05/2002
3	Drug Therapy (Chemotherapy) 10/2016 - 06/2002
1	Splenectomy 04/2010
1	Prostatectomy (Retropubic Prostatectomy) 06/2002